Diag-Nose.io Opens Houston Office following oversubscribed $2M Seed Round to Measure Respiratory Treatment Success Using Proteomics & AI
Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...
Lamar Ledger9h
Breathe Supplement Study: Can This Natural Formula Really Improve Your Lung Health?
Breathing is essential for life, yet for many individuals suffering from chronic respiratory issues such as asthma and COPD, ...
Diag-Nose.io Expands to Bethlehem, PA, Following Oversubscribed $2M Seed Round Funding to Revolutionize Respiratory Diagnostics
Diag-Nose.io sets new standards in respiratory care with AI and proteomics after a $2M seed funding success, now expanding to ...
Diag-Nose.io, Graduate of CDL-Seattle, Closes Oversubscribed $2M Seed Round to Transform Respiratory Care with AI-Driven Precision Medicine
Diag-Nose.io, a CDL-Seattle graduate, harnesses AI with RhinoMAP™ to redefine respiratory care, securing $2M in oversubscribed fundingSEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking ...
Sanofi (SNY) Q4 2024 Earnings Call Transcript
Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...
Earnings call transcript: Sanofi Q4 2024 sees strong growth in sales, EPS
Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...
manilatimes4h
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended ...